CLINICAL_TRIALS
trial_result
· 2007-10-10
Clinical Trial Update: A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia [Phase 2]
Summary
A Phase 2 trial evaluating the safety and efficacy of Bacopa monnieri and Nardostachys jatamansi for schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Q.Mundewadi Ayurvedic Research & Charitable Trust | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED